Cervical leiomyosarcoma: a rare entity

Authors

  • Varsha Bhatia Grant Government Medical College and Sir JJ Group of Hospitals
  • Rahul Taksande Grant Government Medical College and Sir JJ Group of Hospitals
  • Ashwini Natekar Grant Government Medical College and Sir JJ Group of Hospitals
  • Zeba Ali Grant Government Medical College and Sir JJ Group of Hospitals

Keywords:

cervical, leiomyosarcoma, LMS, uterus, rare

Abstract

According to the older literature, leiomyosarcoma (LMS) is the most common sarcoma of the uterus. But in 1993, the Gynecologic Oncology Group (GOG) found that the proportion of LMS of the uterus was only 16% of uterine sarcomas.1,2 However, sarcomas comprise less than 1% of all cervical malignancies,3 of which LMS is an extremely rare tumour, which follows an aggressive course. As per the world literature, only 22 cases4 have been described. To our knowledge only two cases4 have been reported in the Indian literature. We present a case study on a 40-year-old woman of Indian origin, who was diagnosed with cervical LMS.

Author Biographies

  • Varsha Bhatia, Grant Government Medical College and Sir JJ Group of Hospitals
    MD Assistant Professor Department of Pathology Grant Government Medical College and Sir JJ Group of Hospitals Byculla Mumbai Maharashtra
  • Rahul Taksande, Grant Government Medical College and Sir JJ Group of Hospitals
    MD Associate Professor Department of Pathology Grant Government Medical College and Sir JJ Group of Hospitals
  • Ashwini Natekar, Grant Government Medical College and Sir JJ Group of Hospitals
    MBBS Resident Department of Pathology Grant Government Medical College and Sir JJ Group of Hospitals
  • Zeba Ali, Grant Government Medical College and Sir JJ Group of Hospitals
    MBBS Resident Department of Pathology Grant Government Medical College and Sir JJ Group of Hospitals

Downloads

Additional Files

Published

2015-02-17

Issue

Vol. 7 No. 2 (2015)

Section

Short Report

License

South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.